DiaGenic ASA (DiaGenic) is a medical company that creates value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from the absence of dementia. DiaGenic also has IP position, unique access to biobanks and mature technology in late stage development of products for commercialization in major markets. The company’s tests are based on the observation that a focal lesion or disorder gives rise to a systemic response which can be measured in the blood. DiaGenic is headquartered in Oslo, Norway.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company DiaGenic ASA - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Our reports have been used by over 10K customers, including:
Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End Use, And Segment Forecasts, 2021 - 2028
Pharmacovigilance Market Growth & Trends
The global pharmacovigilance...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
Report Scope:
This report analyzes the regulatory framework for the clinical trials of orphan drugs in rare and orphan diseases.The report also analyzes the trends and characteristics of clinical trials conducted on rare diseases from 1999-2018, using information from various sources.
This report covers an overview...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
Medical Information Market Size, Share & Trends Analysis Report By Service Provider (In House, Outsourcing), By Therapeutic Area, By Product Life Cycle, By Company Size, By End-use, By Region, And Segment Forecasts, 2020 - 2027
Medical Information Market Growth & Trends
The global medical...
Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions.It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage.Its major products include cochlear implant...
Clinical Trial
Drug Development
Pharmaceutical
United States
Drug Approval
Medical Devices Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.